1. Home
  2. XTNT vs PLRX Comparison

XTNT vs PLRX Comparison

Compare XTNT & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

N/A

Current Price

$0.52

Market Cap

68.9M

Sector

Health Care

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

74.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XTNT
PLRX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
74.9M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
XTNT
PLRX
Price
$0.52
$1.23
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$1.00
$2.67
AVG Volume (30 Days)
100.5K
487.9K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
29.97
EPS
0.03
N/A
Revenue
$53,337,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.30
N/A
P/E Ratio
$18.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$1.09
52 Week High
$0.95
$1.95

Technical Indicators

Market Signals
Indicator
XTNT
PLRX
Relative Strength Index (RSI) 49.38 44.77
Support Level $0.44 $1.13
Resistance Level $0.67 $1.37
Average True Range (ATR) 0.03 0.05
MACD 0.01 -0.00
Stochastic Oscillator 42.71 30.00

Price Performance

Historical Comparison
XTNT
PLRX

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: